Related Experiment Video
Updated: Oct 7, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Elevated De Ritis Ratio Is Associated With Poor Prognosis in COVID-19: A Systematic Review and Meta-Analysis
Raymond Pranata1, Ian Huang1,2, Michael Anthonius Lim1
1Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia.
Insights
An elevated De Ritis ratio (AST/ALT) is linked to worse outcomes in COVID-19 patients. This finding suggests the ratio can help predict prognosis in coronavirus cases.
Area of Science:
- Medical Diagnostics
- Infectious Diseases
- Biomarkers
Background:
- The De Ritis ratio, or Aspartate aminotransferase/alanine transaminase (AST/ALT) ratio, is a potential indicator of liver function and cellular damage.
- Its association with prognosis in coronavirus 2019 (COVID-19) patients requires comprehensive evaluation.
Approach:
- A systematic literature review and meta-analysis was conducted using data from PubMed, Embase, and EuropePMC databases.
- Eight studies encompassing 4,606 patients were analyzed to assess the relationship between elevated De Ritis ratio and COVID-19 prognosis.
- Key outcomes included mortality, disease severity, ICU admission, and intubation, with statistical measures like odds ratios and mean differences calculated.
Key Points:
- Elevated De Ritis ratio was observed in 44% of patients and was significantly higher in those with poor prognosis (mean difference 0.41) and non-survivors (mean difference 0.47).
- An elevated De Ritis ratio was associated with poor COVID-19 prognosis (OR 3.28), demonstrating a sensitivity of 55% and specificity of 71%.
- The posterior probability of poor prognosis was 38% with an elevated De Ritis ratio, compared to 17% when not elevated.
Conclusions:
- The De Ritis ratio serves as a valuable biomarker for predicting poor prognosis in COVID-19 patients.
- This meta-analysis confirms a significant association between an elevated AST/ALT ratio and adverse outcomes in coronavirus disease.
- Further research may explore the clinical utility of the De Ritis ratio in managing COVID-19 patients.
Abstract:
Objective: This meta-analysis aims to assess whether elevated De Ritis ratio is associated with poor prognosis in patients with coronavirus 2019 (COVID-19). Methods: A systematic literature search was performed using PubMed, Embase, and EuropePMC databases up until September 17, 2021. De Ritis ratio is also known as Aspartate aminotransferase/alanine transaminase (AST/ALT) ratio. The main outcome was poor prognosis, a composite of mortality, severity, the need for ICU care, and intubation. The effect measure was odds ratios (ORs) and mean differences. We generated sensitivity and specificity, negative and positive likelihood ratio (NLR and PLR), diagnostic odds ratio (DOR), and area under curve (AUC). Results: There were eight studies with 4,606 patients. De Ritis ratio was elevated in 44% of the patients. Patients with poor prognosis have higher De Ritis ratio [mean difference 0.41 (0.31, 0.50), p < 0.001; I 2: 81.0%] and subgroup analysis showed that non-survivors also have higher De Ritis Ratio [mean difference 0.47 (0.46, 0.48), p < 0.001; I 2: 0%]. Elevated De Ritis ratio was associated with poor prognosis [OR 3.28 (2.39, 4.52), p < 0.001; I 2: 35.8%]. It has a sensitivity of 55% (36-73), specificity of 71% (52-85), PLR 1.9, NLR.63, DOR of 3 (2-4), and AUC of.67 (0.63-0.71). The posterior probability of poor prognosis was 38% if De Ritis is elevated, while 17% if De Ritis is not elevated. Conclusion: Elevated De Ritis ratio is associated with poor prognosis in patients with COVID-19. Systematic Review Registration: PROSPERO ID: CRD42020216634.
More Related Videos
Related Concept Videos
Relative Risk
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Myocarditis III: Medical Management
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Hazard Ratio
For example, in a clinical trial...

